Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Healthy Returns

Recent news which mentions Healthy Returns

Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Healthy Returns Roche Holding AG Eli Lilly and Co
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
Tags Novavax Inc Pfizer Inc Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
Tags Health care industry Science Sanofi SA
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Healthy Returns Health care industry Eli Lilly and Co
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Johnson & Johnson Health care industry Novartis AG
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Augmedix Inc Health & Science Novo Nordisk A/S
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Novo Nordisk A/S Merck & Co Inc Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Health & Science Pfizer Inc Merck & Co Inc
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Cigna Corp
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Zealand Pharma A/S Health care industry Viking Therapeutics Inc
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Social issues Health & Science Novo Nordisk A/S
From CNBC.com News
Healthy Returns: What we know about the next round of Covid vaccines
Tags Moderna Inc Pfizer Inc Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Eli Lilly and Co Health care industry Johnson & Johnson
From CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
Tags Healthy Returns Johnson & Johnson Science
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Healthy Returns Health care industry Science
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Science Alphabet Inc Eli Lilly and Co
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Abbvie Inc Healthy Returns Alvotech SA
From CNBC.com News
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet
Tags UnitedHealth Group Inc Health care industry Kyverna Therapeutics Inc
From CNBC.com News
Healthy Returns: U.S. drug shortages reach record high, hitting Wegovy, ADHD medications
Tags Biotech and Pharmaceuticals Health care industry UnitedHealth Group Inc
From CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
Tags Health & Science Bristol/Myers Squibb Co Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags AstraZeneca PLC Health & Science Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
Tags AstraZeneca PLC GSK plc Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Tags Aligos Therapeutics Inc Merck & Co Inc Novo Nordisk A/S
From CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
Tags Johnson & Johnson Health care industry Healthy Returns
From CNBC.com News
Healthy Returns: What to know about CDC’s new Covid recommendations
Tags Social issues Healthy Returns Health & Science
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.